Wednesday, April 16, 2014
The Drug Shortage Report: IV Saline Shortage Affects EMMC
The Drug Shortage Report: IV Saline Shortage Affects EMMC: Eastern Maine Medical Center in Bangor is feeling the pinch of a nationwide shortage of IV saline. The solution is vital in keeping patie...
India's Lupin Recalls 10,000 Bottles of Antibacterial Drugs in U.S.
Indian drug maker Lupin's U.S. unit is recalling thousands of bottles of one of its Indian-made antibacterial drugs after finding that they failed to meet U.S. standards for impurities.
Lupin Pharmaceuticals Inc., based in Baltimore, recalled close to 10,000 bottles of the drug made by its Indian parent, Lupin Ltd., the U.S. Food and Drug Administration said on its website. The recall was initiated on Jan. 27 but made public by the FDA this week.
"This is a voluntary recall initiated on our own and of no business consequence," a Lupin spokesman in India said without elaborating
The recall is the latest embarrassing incident for Indian pharmaceutical firms that have thrived in the lucrative market for drugs that have gone off patent.
The U.S. FDA has in recent years increased its vigilance of these firms as India became the second-largest supplier of generic drugs in the U.S.
Lupin—the fifth-largest generic drug maker in the U.S. in terms of prescriptions—gets 40% of its net sales from the U.S.
The latest recall is for Lupin's branded drug Suprax, the brand name for cefixime—an antibiotic used to treat bacterial infections of the ear and upper respiratory tract.
The Indian firm, India's fourth-largest generic drug maker by market capitalization, joins its larger peers in trying to become more vigilant in the face of increasing regulatory scrutiny from the U.S.
Tuesday, April 15, 2014
Tale of two eye drugs plays out in Medicare's doctor reimbursements
Behind ophthalmology's recent ranking as Medicare's highest-reimbursed specialty is a tale of two eye drugs.
Lucentis and Avastin have been shown equally effective in combating age-related macular degeneration, the leading cause of blindness in the elderly. They share a similar molecular make-up and even the same manufacturer.
But the cost per dose is much different: $2,000 versus $50. With a recommended two-year, 24-injection course of treatment, the difference per patient is huge.
Ophthalmologists, who buy the drugs and are then reimbursed for them, used the pricier Lucentis often enough to account for about $1 billion in Medicare spending in 2012, according to recently released data from Centers for Medicare and Medicaid Services. Indeed, Lucentis is a key reason ophthalmologists are at the top of the Medicare list.
Critics say the way doctors are reimbursed under Medicare — the average cost of the drug, plus 6 percent of the cost — sets up a financial incentive to choose the costlier medication. An Ohio ophthalmologist who has been outspoken on the debate, Dr. J. Gregory Rosenthal, said doctors shouldn't use Lucentis.
continue to read here
Lucentis and Avastin have been shown equally effective in combating age-related macular degeneration, the leading cause of blindness in the elderly. They share a similar molecular make-up and even the same manufacturer.
But the cost per dose is much different: $2,000 versus $50. With a recommended two-year, 24-injection course of treatment, the difference per patient is huge.
Ophthalmologists, who buy the drugs and are then reimbursed for them, used the pricier Lucentis often enough to account for about $1 billion in Medicare spending in 2012, according to recently released data from Centers for Medicare and Medicaid Services. Indeed, Lucentis is a key reason ophthalmologists are at the top of the Medicare list.
Critics say the way doctors are reimbursed under Medicare — the average cost of the drug, plus 6 percent of the cost — sets up a financial incentive to choose the costlier medication. An Ohio ophthalmologist who has been outspoken on the debate, Dr. J. Gregory Rosenthal, said doctors shouldn't use Lucentis.
continue to read here
Anti-Death-Penalty Activists Target Pharmacist Association's Ethics Code April 15, 2014
As some states increasingly turn to compounding pharmacies to provide drugs needed for lethal injections, an online petition seeking to change the American Pharmacists Association’s code of ethics is gaining steam. Activists see it as a way to bring more pressure to bear in their fight to end the death penalty for good.
According to some activists, it’s a sentence that could change everything about the death penalty.continue to read here
Raising the Bar on USP 797 Compliance: Building Stronger Staff Competencies Through Automation, Education and Accountability
Written by Jamin Engel, Pharm.D, MBA, Lead Staff Pharmacist, Sterile Products Coordinator, Sentara RMH | April 15, 2014
The introduction of the United States Pharmacopeia Chapter <797> regulation in 2008 sent and continues to send shock waves through hospital pharmacy departments and other sterile drug preparation settings.
Compounding practices that had been ingrained in the pharmaceutical industry for decades were simply turned upside down, and many pharmacies today remain challenged in their pursuit to successfully comply.
The introduction of the United States Pharmacopeia Chapter <797> regulation in 2008 sent and continues to send shock waves through hospital pharmacy departments and other sterile drug preparation settings.
Compounding practices that had been ingrained in the pharmaceutical industry for decades were simply turned upside down, and many pharmacies today remain challenged in their pursuit to successfully comply.
A far-reaching regulation that impacts nearly every step of compounded sterile preparations, the 60-page document requires everything from documentation of compounding activities and staff competencies to compliance with specific architectural and environmental aspects of the clean room. Staff must undergo intensive and continuous education to accurately interpret the extensive protocols found in the all-encompassing regulation to ensure compliance.
continue to read here
Diamondback Drugs Continues Expansion and Announces New Hires, Continued Growth Necessitates Additional Staffing-April 15, 2014
Scottsdale, Arizona's Diamondback Drugs has long been at the forefront of the veterinary pharmaceutical compounding field, and has built a reputation on its fast, friendly service, top-notch products, reasonable prices, and knowledgeable staff. Continued success and growth has brought about the need for recent expansion, and several key new additions to the staff at Diamondback Drugs.
Pharmaceutical compounding allows for veterinary drugs to be formulated into more palatable formats, making the process of administering them less stressful for pet patients and those responsible for their medical care. In addition, compounding pharmacies are often able to create analogs of drugs that have been discontinued by their manufacturers, saving the lives of animals that have become reliant on those medications.
More and more, pet owners and veterinarians are realizing the benefits of pharmaceutical compounding in veterinary medicine. Compounding medications makes it possible for the Veterinarian to choose the specific combination of medication or individual medication dosage and delivery formulation. This reduces stress on both the pet and pet owner aiding in compliance which in turn helps the pet recover or manage their medical condition. Being highly regarded in the burgeoning industry of veterinary pharmaceutical compounding has steadily increased demand for Diamondback Drugs' wide array of products and services. The company continues to experience strong sales, and a rapidly growing customer base.
Of course, increased demand brings a need for more help, and Diamondback Drugs is pleased to announce the hiring of two new Inside Sales/Customer Service Representatives.
Farren Neuhauser Joins the Team at Diamondback Drugs
Farren Neuhauser joins Diamondback from the world of pharmacy technicians, and her skill-set should dovetail quite nicely with Diamondback's field of specialty.
Neuhauser has been an instructor in Arizona College's Pharmacy Technician program, a position that kept her at the forefront of new developments in the pharmaceutical field. Prior to her tenure as an instructor, Farren worked as a CVS Pharmacy Technician.
In addition to her pharmacy background, Ms. Neuhauser is fluent in Spanish, French, and Hebrew, making her ideally suited to communicate the value of Diamondback's products and services to the company's growing international clientele. She holds a B.A. in Linguistics from Temple University College of Health Professions.
Ben Latil Comes on Board at Diamondback Drugs
Inside Sales/ Customer Service will not be Ben Latil's first role with Diamondback Drugs; Latil has previously worked as one of the company's delivery drivers.
Prior to joining the Diamondback team, Mr. Latil worked as a Biology/ Chemistry Lab Assistant at South Mountain Community College, and served his country as an Aviation Electronics Technician with the US Navy. He holds an AA from South Mountain Community College.
About Diamondback Drugs
Scottsdale, Arizona-based Diamondback Drugs specializes in the art and science of veterinary compounding. They offer home delivery, and stock the widest range of medications, chemicals, bases and flavors. Learn more about Diamondback Drugs at their website: http://www.diamondbackdrugs.com/ or call them direct at 866-578-4420.
Read the full story at http://www.prweb.com/releases/veterinary/pharmacy/prweb11762262.htm
Pharmaceutical compounding allows for veterinary drugs to be formulated into more palatable formats, making the process of administering them less stressful for pet patients and those responsible for their medical care. In addition, compounding pharmacies are often able to create analogs of drugs that have been discontinued by their manufacturers, saving the lives of animals that have become reliant on those medications.
More and more, pet owners and veterinarians are realizing the benefits of pharmaceutical compounding in veterinary medicine. Compounding medications makes it possible for the Veterinarian to choose the specific combination of medication or individual medication dosage and delivery formulation. This reduces stress on both the pet and pet owner aiding in compliance which in turn helps the pet recover or manage their medical condition. Being highly regarded in the burgeoning industry of veterinary pharmaceutical compounding has steadily increased demand for Diamondback Drugs' wide array of products and services. The company continues to experience strong sales, and a rapidly growing customer base.
Of course, increased demand brings a need for more help, and Diamondback Drugs is pleased to announce the hiring of two new Inside Sales/Customer Service Representatives.
Farren Neuhauser Joins the Team at Diamondback Drugs
Farren Neuhauser joins Diamondback from the world of pharmacy technicians, and her skill-set should dovetail quite nicely with Diamondback's field of specialty.
Neuhauser has been an instructor in Arizona College's Pharmacy Technician program, a position that kept her at the forefront of new developments in the pharmaceutical field. Prior to her tenure as an instructor, Farren worked as a CVS Pharmacy Technician.
In addition to her pharmacy background, Ms. Neuhauser is fluent in Spanish, French, and Hebrew, making her ideally suited to communicate the value of Diamondback's products and services to the company's growing international clientele. She holds a B.A. in Linguistics from Temple University College of Health Professions.
Ben Latil Comes on Board at Diamondback Drugs
Inside Sales/ Customer Service will not be Ben Latil's first role with Diamondback Drugs; Latil has previously worked as one of the company's delivery drivers.
Prior to joining the Diamondback team, Mr. Latil worked as a Biology/ Chemistry Lab Assistant at South Mountain Community College, and served his country as an Aviation Electronics Technician with the US Navy. He holds an AA from South Mountain Community College.
About Diamondback Drugs
Scottsdale, Arizona-based Diamondback Drugs specializes in the art and science of veterinary compounding. They offer home delivery, and stock the widest range of medications, chemicals, bases and flavors. Learn more about Diamondback Drugs at their website: http://www.diamondbackdrugs.com/ or call them direct at 866-578-4420.
Read the full story at http://www.prweb.com/releases/veterinary/pharmacy/prweb11762262.htm
Another Compounding Representative Job Opening--This Time in Houston--Stating top reps earn $40k their second month (targeting 2-3 doctors)
Compounding Speciality Representative
Company: N/A
Location: Houston, TX
Pay: N/A
| Contact InformationName: Tamara Paul Phone: (614) 654-1154 Fax: n/a |
| Apply Online | |
Job Description
Have you heard of the compound sales industry? If not, you owe it to yourself to check it out!!!
We have immediate openings for self-motivated business minded people to join this life changing opportunity. Our position requires the ability to work independently and manage your own business. We offer a unique sales opportunity for you to leverage current relationships to quickly generate a substantial residual income. We are looking for pharmaceutical and medical sales representatives with established relationships in the ENT, Allergy, dermatology and surgical specialties. If you have the relationships in place and a consistent work ethic, it’s impossible not to earn significant income!
Job Requirements
We have immediate openings for self-motivated business minded people to join this life changing opportunity. Our position requires the ability to work independently and manage your own business. We offer a unique sales opportunity for you to leverage current relationships to quickly generate a substantial residual income. We are looking for pharmaceutical and medical sales representatives with established relationships in the ENT, Allergy, dermatology and surgical specialties. If you have the relationships in place and a consistent work ethic, it’s impossible not to earn significant income!
Job Requirements
Our compound pharmacy offers:
About our pharmacy:
If interested please submit your resume to [Click Here to Email Your Resumé]
quoted from here
- A lucrative commission structure!! Top reps have earned $40k their second month. (Targeting 2-3 physicians)
- Real time tracking of prescriptions being written and an email alert when the status changes.
- A state-of-the-art database for you to track your commissions paid.
- Zero investment… The company pays for all your start up marketing material.
- W-2 employee, (Part-Time Independent Contractor)
- Opportunity to become a distributor and recruit your own team.
About our pharmacy:
- Licensed in every state including Puerto Rico and Guam.
- An extensive pipe-line.
- Offers compliance testing to protect the integrity of our business.
- Fully accredited for almost 25 years.
- Sales leadership and training program.
- Over 1900 insurance payers.
- Over 50,000 transdermal patients nationwide
If interested please submit your resume to [Click Here to Email Your Resumé]
quoted from here
Subscribe to:
Posts (Atom)